CompletedPhase 4

Hyaluronic Acid Versus Red Injectable Platelet Rich Fibrin in Treatment of Periodontitis

Lebanon75 participantsStarted 2021-03-01

Plain-language summary

the aim of this clinical trial is to compare the efficacy of hyaluronic acid (HA) used as an adjunctive to scaling and root planing (SRP) and red injectable platelet rich-fibrin (i-PRF) in the non-surgical treatment of stage III periodontitis. The main question it aims to answer is: is there a difference between HA and red i-prf when used as an adjunct to SRP in terms of efficacy? Participants who are eligible will be assigned to one of the treatment groups: * Group 1= receives HA+ SRP * Group 2= receives red i-prf + SRP * Group 3= receives only SRP Researchers will compare Groups 1,2 and 3 to see if there's a difference in the periodontal parameters measured.

Who can participate

Age range20 Years – 60 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * clinical periodontal loss and radiographic bone loss of stage III/grades A and B with no history of systemic disease. * at least four periodontal sites with a pocket depth of six mm or greater * radiographic evidence of bone loss extending to the middle third of the root * clinical attachment loss of five mm or more Exclusion Criteria: * uncontrolled systemic conditions (uncontrolled diabetes or uncontrolled hypertension) * bleeding disorders, or on anticoagulant therapy * alcohol users * pregnant or lactating females * heavy smokers (more than ten cigarettes per day) * chemo or radio therapy * antibiotic/anti-inflammatory drugs over the last three months before treatment.

What they're measuring

Clinical Attachment Level

Timeframe: 4 weeks

Probing Depth

Timeframe: 4 weeks

Trial details

NCT IDNCT05768243

SponsorBeirut Arab University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2022-07-24